Search results
U.S. Senator Chuck Grassley Welcomes Oversight of Over-The-Counter Hearing Aids
Sierra Sun Times· 4 hours agoElizabeth Warren (D-Mass.) championed in 2017. For five years following enactment, Grassley and...
Supreme Court crunch time as Trump, abortion and social media decisions loom
USA Today· 4 days agoThe justices still have 32 decisions to release before their July recess, and several are poised to...
Netflix, Inc. (NASDAQ:NFLX) Stock Position Decreased by Wittenberg Investment Management Inc.
ETF DAILY NEWS· 9 hours agoThe institutional investor owned 4,998 shares of the Internet television network’s stock after...
Jeffrey Bucholtz on Food and Drug Administration (FDA) | JD Supra
JD Supra· 6 days agoJD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations. This Privacy Policy describes how JD Supra ...
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 4 days agoThe conference was a big one for Summit Therapeutics, which saw its stock price more than double...
‘What is the difference?’: Walmart customer shows Zyrtec is $42 but generic brand is $6
The Daily Dot· 2 days agoA young woman shopping for Zyrtec at Walmart learned a little bit about how the world works while...
Raw Milk and the Rise of ‘Food Freedom’
The Wall Street Journal· 4 days agoInterest in unpasteurized dairy is soaring despite health risks, thanks to lifestyle influencers, commentators and politicians promoting its consumption.
Cheaper Ozempic Alternatives Are Out There. Be Wary of Fakes and Fraudsters.
The Wall Street Journal· 3 days agoMillions of people are taking Ozempic, Wegovy or Mounjaro for weight loss. Compounded drugs are...
Meta AI chief LeCun slams Elon Musk over 'blatantly false' predictions, spreading conspiracy...
CNBC· 5 days agoMeta's chief artificial intelligence scientist Yann LeCun has spent much of the past week sparring...
VEON (NASDAQ:VEON) Upgraded by StockNews.com to Buy
ETF DAILY NEWS· 12 hours agoStockNews.com upgraded shares of VEON (NASDAQ:VEON – Free Report) from a hold rating to a buy rating in a report issued on Saturday. VEON Price Performance Shares of NASDAQ:VEON opened at $26.94 ...
